PF-Atlas › Mechanisms › Prostacyclin analog — vasodilation + anti-fibrotic + anti-proliferative in pulmonary vasculature and parenchyma
Prostacyclin analog — vasodilation + anti-fibrotic + anti-proliferative in pulmonary vasculature and parenchyma in IPF
Mechanism of action · idiopathic pulmonary fibrosis
Overview
Prostacyclin analog — vasodilation + anti-fibrotic + anti-proliferative in pulmonary vasculature and parenchyma is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 0 clinical trials acting through this mechanism.
Drugs targeting Prostacyclin analog — vasodilation + anti-fibrotic + anti-proliferative in pulmonary vasculature and parenchyma
Therapies
Medical disclaimer. This is a research summary, not medical advice.